| | | | | | | |
 | CSL LIMITED | -0.18% | 1.79% | -1.75% | 1.59% | 29.06% | 90 967 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -0.42% | 10.06% | -10.43% | -38.36% | 238.60% | 44 412 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -0.62% | 1.27% | -11.41% | -5.88% | 154.78% | 43 617 |
 | BIOGEN INC. | 1.60% | 5.24% | -9.98% | -37.38% | -7.80% | 31 133 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | -5.47% | 2.13% | -9.01% | -34.09% | 153.11% | 28 559 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | 0.49% | 4.96% | 6.70% | -8.26% | --.--% | 21 250 |
 | UCB | 3.27% | 3.87% | -15.00% | -3.88% | 14.62% | 16 008 |
| BIOMARIN PHARMACEUTICAL INC. | 0.06% | 2.97% | -2.20% | 2.18% | 5.38% | 15 976 |
| WALVAX BIOTECHNOLOGY CO., LTD. | -2.02% | 1.43% | -12.67% | -12.93% | 67.68% | 11 940 |
 | GRIFOLS, S.A. | -3.50% | -0.26% | 0.41% | -24.35% | -39.11% | 10 586 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -1.55% | -5.11% | -13.12% | -52.99% | --.--% | 9 813 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | 0.23% | -7.27% | -23.79% | -21.84% | 46.60% | 8 918 |
| CELLTRION HEALTHCARE CO., LTD. | 1.54% | 5.83% | -9.48% | -35.44% | 36.74% | 8 443 |
| SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. | -2.62% | -1.44% | -27.70% | -52.00% | 19.34% | 7 626 |
| INNOVENT BIOLOGICS, INC. | -2.23% | 5.27% | -22.69% | -56.83% | 37.38% | 7 280 |
| | | | | | | |
| | Moyenne | -0.76% | 2.05% | -10.81% | -25.36% | 58.18% | |
| | Moyenne pondérée par Capi. | -0.57% | 3.03% | -7.76% | -17.93% | 79.83% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
